The relative risk of viral shedding with pritelivir , as compared with placebo , was @ ( @ % confidence interval -LSB- CI -RSB- , @ to @ ) with the @-mg daily dose , @ ( @ % CI , @ to @ ) with the @-mg daily dose , @ ( @ % CI , @ to @ ) with the @-mg daily dose , and @ ( @ % CI , @ to @ ) with the @-mg weekly dose .